biostudies-literatureUnknown15(6)Hudec M<h4>Background</h4>This study evaluated the safety and efficacy of BioMime sirolimus-eluting stent (SES) system, with an ultra-low strut thickness (65 µm), in real-world all-comers population with coronary artery stenosis (CAD).<h4>Methods</h4>This was a post-marketing, multicenter, single-arm, observational clinical registry among patients undergoing intervention for CAD. Patients were clinically followed up at 1, 9, 12, and 24 months after the index percutaneous coronary intervention. Four major indications, namely long stents of > 30 mm, stents with diameters of 4 and 4.5 mm, bifurcation subgroup, and chronic total occlusion (CTO) were evaluated as pre-specified subsets.<h4>Results</h4>A total of 771 patients (1,079 treated lesions) from 23 sites were included in this study. The mean leCardiology research439-452https://www.ebi.ac.uk/biostudies/studies/S-EPMC11650571biostudies-literatureSafety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global Registry.PMC11650571de Costa JMValdes MMar GYWang YCChae IHMayurathan GMerkely BSadeghian MKhokhlov ASerra ACharng MJTrillo RHwang SJGwon HCMaskon OMateev HCale RLawand SHudec MIjsselmuiden AJJJeong MHMontilla BVBurgos JMfalseSafety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global Registry.<h4>Background</h4>This study evaluated the safety and efficacy of BioMime sirolimus-eluting stent (SES) system, with an ultra-low strut thickness (65 µm), in real-world all-comers population with coronary artery stenosis (CAD).<h4>Methods</h4>This was a post-marketing, multicenter, single-arm, observational clinical registry among patients undergoing intervention for CAD. Patients were clinically followed up at 1, 9, 12, and 24 months after the index percutaneous coronary intervention. Four major indications, namely long stents of > 30 mm, stents with diameters of 4 and 4.5 mm, bifurcation subgroup, and chronic total occlusion (CTO) were evaluated as pre-specified subsets.<h4>Results</h4>A total of 771 patients (1,079 treated lesions) from 23 sites were included in this study. The mean le2024-01-01T00:00:00Z2024 Dec2025-04-04T21:44:02.11Z2025-04-04T21:44:02.11ZS-EPMC116505713969800910.14740/cr1724